text: Lilly expands its cancer drug work with bet on dual-acting antibodies - BioPharma Dive
  20 cancer drugs approved in 2020 - Becker's Hospital Review
  Single-cell test can reveal precisely how drugs kill cancer cells - EurekAlert
  Global Blood Cancer Drugs Market (2020 to 2026) - Industry Analysis, Trends, Market Size, and Forecasts - ResearchAndMarkets.com - Yahoo Finance
  7 Recent Cancer Drug Approvals Patients May Have Missed - Curetoday.com
  Outlook on the Blood Cancer Drugs Global Market to 2026 - by Product, Treatment Approach, Application and Region - GlobeNewswire
  on January 20, 2021 at 1:16 am
  A young mum with less than a year to live is to be given a 'miracle' drug that could extend her life and let her spend more time with her little boy. Natalie Sanders suffers from deadly Grade 3 Triple ...
  on January 20, 2021 at 1:09 am
  Drug companies AstraZeneca and Daiichi Sankyo said their Enhurtu breast cancer drug had won conditional approval in the European Union.
  on January 19, 2021 at 1:02 pm
  Mechanism-based adverse events (AEs) predominated in the safety profile, notably hypophosphatemia and eye disorders, reported Milind Javle, MD, of the MD Anderson Cancer Center in Houston, at the ...
  AstraZeneca and Daiichi Sankyo's breast cancer drug has been approved as a treatment for a certain type of advanced gastric cancer in the United States, the British drugmaker said on Monday.